Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04570839
Title COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Compugen Ltd
Indications

ovary epithelial cancer

fallopian tube carcinoma

Advanced Solid Tumor

peritoneal carcinoma

endometrial cancer

Therapies

BMS-986207 + COM701 + Nivolumab

Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.